We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
OTEZLA (Amgen Australia Pty Ltd)
Product name
OTEZLA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
183 (255 working days)
Active ingredients
apremilast
Registration type
EOI
Indication
- The treatment of adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.
- The treatment of adult patients with oral ulcers associated with Behçet’s Disease who are candidates for systemic therapy.